Skip to Content

Pharmaceutical Sales 2007

The following is a list of the top 200 pharmaceutical drugs by retail sales in 2007, listed by U.S. sales value and brand name.
Quarterly top 100 prescription sales data now available, from Q1 2011.

Top 200 Drugs for 2007 by Sales

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Rank Drug Current Manufacturer Total Sales ($000) % Change 2006
1 Lipitor Pfizer Inc. 6,165,531 -6.3%
2 Nexium AstraZeneca 4,355,901 7.3%
3 (1) Advair Diskus GlaxoSmithKline 3,390,766 8.8%
4 (1) Prevacid Takeda Pharmaceutical Company Limited 3,315,740 0.3%
5 (2) Plavix Bristol-Myers Squibb Company 3,082,712 38.1%
6 (1) Singulair Merck 2,863,326 16.4%
7 (4) Seroquel AstraZeneca 2,518,409 21.4%
8 (2) Effexor XR Pfizer Inc. 2,464,396 9.7%
9 (1) Lexapro Actavis Pharma, Inc. 2,304,364 9.8%
10 (4) Actos Takeda Pharmaceutical Company Limited 2,229,333 15.7%
11 (1) Protonix Pfizer Inc. 2,136,899 5.7%
12 (10) Vytorin Merck 1,938,882 32.0%
13 (7) Topamax Janssen Pharmaceuticals, Inc. 1,837,388 20.8%
14 (4) Risperdal Janssen Pharmaceuticals, Inc. 1,790,436 8.1%
15 (9) Abilify Bristol-Myers Squibb Company 1,781,562 25.7%
16 (19) Cymbalta Eli Lilly and Company 1,732,827 59.8%
17 (9) Lamictal GlaxoSmithKline 1,717,429 29.4%
18 (1) Zyprexa Eli Lilly and Company 1,579,252 2.8%
19 (6) Levaquin Janssen Pharmaceuticals, Inc. 1,433,000 1.7%
20 (7) Celebrex Pfizer Inc. 1,416,084 7.6%
21 (11) Zetia Merck 1,405,066 23.3%
22 (9) Valtrex GlaxoSmithKline 1,395,313 21.3%
23 (14) Crestor AstraZeneca 1,367,276 29.2%
24 (1) Fosamax Merck 1,355,725 -5.0%
25 (4) Zyrtec Johnson & Johnson Consumer Inc. 1,302,807 12.0%
26 (12) Lantus Sanofi 1,302,555 23.1%
27 (6) Adderall XR Takeda Pharmaceutical Company Limited 1,288,884 13.9%
28 (11) Diovan Novartis Pharmaceuticals Corporation 1,117,415 15.0%
29 (12) Avandia GlaxoSmithKline 1,110,458 -33.3%
30 (10) Tricor Abbott Laboratories 1,106,518 14.6%
31 (3) Aciphex Eisai Inc. 1,099,427 -1.2%
32 (10) Diovan HCT Novartis Pharmaceuticals Corporation 1,051,823 21.4%
33 (18) OxyContin Purdue Pharma LP 1,043,703 52.8%
34 (7) Concerta Janssen Pharmaceuticals, Inc. 1,030,703 10.1%
35 (5) Coreg GlaxoSmithKline 1,013,939 -12.5%
36 (11) Flomax Boehringer Ingelheim Pharmaceuticals, Inc. 1,002,163 27.6%
37 (15) Lyrica Pfizer Inc. 1,000,069 53.6%
38 (22) Wellbutrin XL Bausch Health Companies Inc. 992,372 -40.6%
39 (5) Aricept Eisai Inc. 983,397 22.9%
40 (3) Imitrex Oral GlaxoSmithKline 950,585 10.8%
41 (28) Ambien Pfizer Inc. 920,070 -52.5%
42 (14) Lotrel Novartis Pharmaceuticals Corporation 908,174 -29.8%
43 (2) Nasonex Merck 892,534 13.1%
44 (23) Toprol XL AstraZeneca 888,208 -39.7%
45 (22) Ambien CR Sanofi 876,028 58.4%
46 (10) Enbrel Amgen Inc. 874,840 -19.3%
47 (12) Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. 868,226 46.3%
48 (2) Viagra Pfizer Inc. 824,946 4.9%
49 (6) Lidoderm Endo Pharmaceuticals Inc. 808,118 27.1%
50 (2) Actonel Actavis Pharma, Inc. 791,023 1.3%
51 () Chantix Pfizer Inc. 764,723 777.5%
52 (43) Norvasc Pfizer Inc. 749,521 -65.1%
53 (5) Lovenox Sanofi 746,154 25.1%
54 Provigil Cephalon, Inc. 744,625 15.5%
55 (6) Lunesta Sepracor Inc. 712,740 22.1%
56 (6) Altace King Pharmaceuticals, Inc. 710,056 -1.0%
57 (24) Keppra UCB, Inc. 708,462 42.0%
58 (14) Geodon Oral Pfizer Inc. 665,033 25.6%
59 (3) Cozaar Merck 652,032 5.4%
60 Detrol LA Pfizer Inc. 635,709 8.8%
61 () Atripla Bristol-Myers Squibb Company 617,195 471.0%
62 (4) Truvada Gilead Sciences, Inc. 606,223 6.4%
63 (15) CellCept Genentech, Inc. 599,290 18.1%
64 (9) Pulmicort Respules AstraZeneca 592,447 13.8%
65 (6) Humalog Eli Lilly and Company 592,322 11.0%
66 (14) Depakote ER Abbott Laboratories 577,034 15.0%
67 (2) Depakote Abbott Laboratories 573,990 5.9%
68 (4) Premarin Tabs Pfizer Inc. 557,390 -3.3%
69 (7) Synthroid Abbott Laboratories 547,587 -5.5%
70 (15) Niaspan Abbott Laboratories 546,407 15.3%
71 (26) Byetta Amylin Pharmaceuticals, Inc. 541,012 49.0%
72 () Budeprion XL Teva Pharmaceuticals USA, Inc. 537,370 >999
73 (10) Strattera Eli Lilly and Company 535,516 -7.3%
74 (4) Combivent Boehringer Ingelheim Pharmaceuticals, Inc. 534,045 -0.1%
75 (1) Trileptal Novartis Pharmaceuticals Corporation 532,376 3.7%
76 Yasmin 28 Bayer HealthCare Pharmaceuticals Inc. 528,314 4.0%
77 (6) Flovent HFA GlaxoSmithKline 521,165 9.3%
78 (4) Skelaxin Elan Corporation plc 517,367 7.1%
79 (7) Prograf Astellas Pharma US, Inc. 515,999 15.7%
80 (7) Arimidex AstraZeneca 506,414 13.5%
81 (4) Evista Eli Lilly and Company 503,390 -0.9%
82 (2) Hyzaar Merck 499,947 5.3%
83 (9) Namenda Actavis Pharma, Inc. 489,713 26.6%
84 () Januvia Merck 471,698 >999
85 (6) Humira Abbott Laboratories 462,619 -8.5%
86 (7) Cialis Eli Lilly and Company 453,233 20.8%
87 (7) Reyataz Bristol-Myers Squibb Company 438,766 17.7%
88 (2) Xalatan Pfizer Inc. 430,887 6.7%
89 (40) Omnicef Abbott Laboratories 429,207 -44.5%
90 (12) Avelox Bayer HealthCare Pharmaceuticals Inc. 424,410 26.5%
91 () ProAir HFA Teva Pharmaceuticals USA, Inc. 421,205 678.6%
92 (1) Asacol Actavis Pharma, Inc. 420,880 8.4%
93 (11) Benicar HCT Daiichi Sankyo 414,253 24.1%
94 () Fentanyl Oral Citrate 408,202 515.9%
95 (27) Requip GlaxoSmithKline 407,665 56.3%
96 (23) Boniva Genentech, Inc. 404,109 49.5%
97 (24) Caduet Pfizer Inc. 388,401 0.2%
98 (2) Avapro Bristol-Myers Squibb Company 384,664 0.2%
99 (2) Gleevec Novartis Pharmaceuticals Corporation 384,572 13.7%
100 Kaletra Abbott Laboratories 373,247 6.0%
101 (6) Ortho Tri-Cyclen Lo Janssen Pharmaceuticals, Inc. 371,544 -0.1%
102 (6) Benicar Daiichi Sankyo 369,641 18.2%
103 (10) AndroGel Abbott Laboratories 366,053 23.8%
104 (3) Xopenex Akorn, Inc. 354,528 10.8%
105 (17) Procrit Janssen Biotech, Inc. 353,189 -15.6%
106 (49) Lamisil Oral Novartis Pharmaceuticals Corporation 339,700 -44.6%
107 (4) Avalide Bristol-Myers Squibb Company 328,733 9.3%
108 (4) Nasacort AQ Sanofi 318,329 6.3%
109 (10) Combivir GlaxoSmithKline 318,175 -10.6%
110 (7) Allegra-D 12 Hour Sanofi 316,629 -5.5%
111 (13) Duragesic Janssen Pharmaceuticals, Inc. 306,188 -14.3%
112 (3) Copaxone Accredo Health Group, Inc. 303,546 -0.7%
113 (20) RenaGel Genzyme Corporation 293,520 29.8%
114 (16) Femara Novartis Pharmaceuticals Corporation 293,473 23.6%
115 () Enbrel Sureclick Amgen Inc. 293,334 539.1%
116 (13) NovoLog Mix 70/30 Novo Nordisk 292,372 22.8%
117 (11) Clarinex Merck 288,965 -8.6%
118 (10) Aldara Medicis Pharmaceutical Corporation 287,596 18.4%
119 (5) Forteo Eli Lilly and Company 282,368 -4.3%
120 (78) Suboxone Reckitt Benckiser Pharmaceuticals Inc. 282,277 105.9%
121 (25) Avodart GlaxoSmithKline 281,353 45.9%
122 (17) Paxil CR Apotex Corp. 280,659 -14.2%
123 (2) Norvir Abbott Laboratories 275,199 10.3%
124 (75) Avandamet GlaxoSmithKline 275,098 101.6%
125 (13) Restasis Actavis Pharma, Inc. 274,733 31.7%
126 (10) Avonex Biogen 266,929 -7.7%
127 (28) Sensipar Amgen Inc. 266,344 49.8%
128 (2) Tarceva Astellas Pharma US, Inc. 263,888 7.5%
129 (14) Patanol Alcon 258,569 -11.1%
130 () Yaz Bayer HealthCare Pharmaceuticals Inc. 254,592 584.0%
131 () Lovaza GlaxoSmithKline 252,684 121.5%
132 (13) Mirapex Boehringer Ingelheim Pharmaceuticals, Inc. 249,807 26.5%
133 (43) Focalin XR Novartis Pharmaceuticals Corporation 249,083 56.6%
134 Cosopt Akorn, Inc. 242,791 8.5%
135 (4) Zyvox Pfizer Inc. 236,407 15.5%
136 (14) Epzicom GlaxoSmithKline 230,664 27.2%
137 (24) NuvaRing Merck 230,608 33.2%
138 (70) Actiq Abbott Laboratories 230,068 -57.9%
139 (61) Fosamax Plus D Merck 229,969 69.1%
140 () Actoplus Met Takeda Pharmaceutical Company Limited 229,800 94.9%
141 Lumigan Actavis Pharma, Inc. 226,765 11.4%
142 (18) Rhinocort Aqua AstraZeneca 225,667 -11.4%
143 () Solodyn Medicis Pharmaceutical Corporation 224,549 247.7%
144 (26) Thalomid Bristol-Myers Squibb Company 222,918 -18.6%
145 (22) Fuzeon Genentech, Inc. 220,522 -13.9%
146 (2) Astelin Meda U.S. 219,377 17.3%
147 (5) BenzaClin Sanofi 213,158 5.0%
148 (8) Relpax Pfizer Inc. 212,412 3.9%
149 (14) Viread Gilead Sciences, Inc. 210,770 -5.8%
150 (3) Casodex AstraZeneca 207,469 7.7%
151 (2) Vigamox Alcon 207,107 12.2%
152 () Vesicare Astellas Pharma US, Inc. 205,637 77.6%
153 (10) Humalog Mix 75/25 Pn 204,322 2.0%
154 (18) Trizivir GlaxoSmithKline 203,230 -8.7%
155 (18) Budeprion SR Teva Pharmaceuticals USA, Inc. 201,458 -4.6%
156 (4) Xeloda Genentech, Inc. 201,453 12.2%
157 (47) Sustiva Bristol-Myers Squibb Company 200,006 -33.5%
158 (2) Levitra Bayer HealthCare Pharmaceuticals Inc. 197,578 11.4%
159 (27) Endocet Endo Pharmaceuticals Inc. 193,882 -14.5%
160 (32) Risperdal Consta Janssen Pharmaceuticals, Inc. 193,837 36.1%
161 (24) Aggrenox Boehringer Ingelheim Pharmaceuticals, Inc. 193,202 27.1%
162 () Humira Pen Abbott Laboratories 191,244 741.1%
163 (20) Kadian Actavis Pharma, Inc. 191,097 23.6%
164 (1) Differin Galderma Laboratories, L.P. 188,171 11.4%
165 (5) Catapres-TTS Boehringer Ingelheim Pharmaceuticals, Inc. 187,374 7.6%
166 (2) Alphagan P Actavis Pharma, Inc. 186,087 9.7%
167 (14) Tussionex Sanofi 179,288 -0.1%
168 (5) Zyrtec Syrup 177,659 3.7%
169 (21) Maxalt Merck 176,736 22.4%
170 (155) Zoloft Pfizer Inc. 175,209 -90.1%
171 (12) Prilosec AstraZeneca 174,360 -0.2%
172 (7) Ciprodex Otic Alcon 174,205 10.6%
173 (16) Temodar Merck 173,446 -2.1%
174 (7) Tobradex Alcon 172,827 3.7%
175 (9) Zyrtec-D Johnson & Johnson Consumer Inc. 163,579 -2.6%
176 () Welchol Daiichi Sankyo 161,769 23.8%
177 (18) Maxalt MLT 161,644 15.5%
178 () Asmanex Merck 161,181 75.0%
179 (2) Atacand AstraZeneca 160,656 2.6%
180 (26) Coumadin Tabs Bristol-Myers Squibb Company 160,548 -10.2%
181 (10) Dovonex Bristol-Myers Squibb Company 159,439 11.1%
182 (13) Klor-Con Sandoz Inc. 159,314 -2.4%
183 (1) Pegasys Genentech, Inc. 156,056 0.7%
184 () Ultram ER Janssen Pharmaceuticals, Inc. 155,482 117.0%
185 (7) Betaseron Bayer HealthCare Pharmaceuticals Inc. 151,954 -3.8%
186 () Zovirax Topical GlaxoSmithKline 151,892 18.8%
187 (7) Trinessa Actavis Pharma, Inc. 151,782 -3.6%
188 Pulmozyme Genentech, Inc. 150,833 3.7%
189 (15) Neupogen Amgen Inc. 150,110 -5.8%
190 (20) Humulin N Eli Lilly and Company 149,884 -8.2%
191 () Micardis HCT Abbott Laboratories 148,149 34.0%
192 (61) Ortho Evra Janssen Pharmaceuticals, Inc. 148,137 -36.4%
193 () Allegra-D 24 Hour Sanofi 148,044 34.2%
194 () Fentora Cephalon, Inc. 147,533 762.8%
195 () Enablex Actavis Pharma, Inc. 147,373 61.5%
196 (24) Famvir GlaxoSmithKline 146,793 -8.6%
197 (10) Avinza King Pharmaceuticals, Inc. 145,694 -2.5%
198 (2) Prempro Pfizer Inc. 144,877 4.4%
199 () Coreg CR GlaxoSmithKline 144,854 NA
200 () Marinol Roxane Laboratories, Inc. 144,668 14.3%
All Others 25,961,547 -11.7%

Source: Verispan, VONA

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012